Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
Share of services in exports rises to 48.8% in FY26India's services exports have seen significant growth. The services sector now accounts for nearly half of the country's total exports. Thi...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapseThe US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
Saving supply chains from climate shocks is a lure for investorsCompanies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...
India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...
Hantavirus scare a wake-up call: Why India must build its disease X defencesA recent hantavirus outbreak on a cruise ship echoes past pandemic scares. Experts warn Disease X, a future unknown pathogen, is a near cer...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Hantavirus outbreak: How an African lab identified the deadly Andes strainA hantavirus scare aboard a cruise ship off Cape Verde prompted a rapid scientific response, with researchers in Senegal quickly identifyin...
Online medicine sale fight: 20,000 chemists in Karnataka to halt work May 20Over 20,000 chemists in Karnataka will shut down their stores on May 20. This is part of a nationwide protest against online pharmacies. Th...
Thailand cuts visa-free stays for more than 90 countries, citing crime by foreignersThailand is drastically cutting the length of visa-free stays for tourists from more than 90 countries in an effort to curb crime involving...
FDA drug center head fired after commissioner's exit, replaced by DavisThe U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...